FROM A-LEVELS OR AN OVERSEAS DEGREE TO PRACTISING IN THE UKSearch the guide
← All news
NEW MEDICINES AND DRUG DISCOVERY · MHRA (UK MEDICINES REGULATOR) · 29 October 2026

Class 2 Medicines Recall: Advanz Pharma Limited, Mynzepli 40 mg/mL solution for injection in pre-filled syringe, EL(26)A/44

Synopsis

Advanz Pharma Limited are recalling specified batches of Mynzepli 40 mg/mL solution for injection in pre-filled syringe as a precautionary measure. Mynzepli 40 mg/mL solution for injection in pre-filled syringe

Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.

Read the full story at MHRA (UK medicines regulator) ↗

More in New medicines and drug discovery